| Lung regeneration: endogenous and exogenous stem cell mediated therapeutic approaches KM Akram, N Patel, MA Spiteri, NR Forsyth International Journal of Molecular Sciences 17 (1), 128, 2016 | 91 | 2016 |
| Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters N Patel, J Belcher, G Thorpe, NR Forsyth, MA Spiteri Respiratory research 16, 1-15, 2015 | 62 | 2015 |
| Chronic obstructive pulmonary disease patients’ experiences of an enhanced self-management model of care N Patel, P Jones, V Adamson, M Spiteri, K Kinmond Qualitative health research 26 (4), 568-577, 2016 | 30 | 2016 |
| Validation of COPDPredict™: unique combination of remote monitoring and exacerbation prediction to support preventative management of COPD exacerbations N Patel, K Kinmond, P Jones, P Birks, MA Spiteri International journal of chronic obstructive pulmonary disease, 1887-1899, 2021 | 28 | 2021 |
| Interventions to increase the rate of influenza and pneumococcal vaccination in patients with chronic obstructive pulmonary disease: a scoping review SP Trethewey, N Patel, AM Turner Medicina 55 (6), 277, 2019 | 9 | 2019 |
| P111 FTIR Spectroscopic profiling of COPD sputum: identification of distinct spectral signatures and correlation to COPD status N Patel, P Coleborn, A Hampton, V Campbell, M Allen, A Gahkani, ... Thorax 65 (Suppl 4), A124-A125, 2010 | 4 | 2010 |
| Phase III, two arm, multi-centre, open label, parallel-group randomised designed clinical investigation of the use of a personalised early warning decision support system to … D Kaur, RL Mehta, H Jarrett, S Jowett, NK Gale, AM Turner, M Spiteri, ... BMJ open 13 (3), e061050, 2023 | 2 | 2023 |
| S66 Levels of salivary c-reactive protein, procalcitonin and neutrophil elastase can predict exacerbations in copd and determine those patients at high risk of re-exacerbation N Patel, G Thorpe, P Jones, V Adamson, J Belcher, MA Spiteri Thorax 71 (Suppl 3), A39-A40, 2016 | 2 | 2016 |
| Sample collection MS Spiteri, N Patel US Patent 10,390,804, 2019 | 1 | 2019 |
| P64 Evaluation Of Saliva Biomarkers As Indicators Of Health Status And Exacerbations In Copd N Patel, P Jones, V Adamson, G Thorpe, J Belcher, M Spiteri Thorax 69 (Suppl 2), A102-A103, 2014 | 1 | 2014 |
| Phase III Two Arm, Multi-centre, Open Label, Parallel-group Randomised Designed Clinical Investigation of the Use of a Personalised Early Warning Decision Support System to … AM Turner, E Gkini, R Mehta, S Tearne, L Doos, N Patel, M Spiteri A27. EMERGING TREATMENTS AND THERAPEUTIC STRATEGIES IN COPD: RESULTS OF …, 2024 | | 2024 |
| Protocol: Phase III, two arm, multi-centre, open label, parallel-group randomised designed clinical investigation of the use of a personalised early warning decision support … D Kaur, RL Mehta, H Jarrett, S Jowett, NK Gale, AM Turner, M Spiteri, ... BMJ Open 13 (3), 2023 | | 2023 |
| Sample collection MS Spiteri, N Patel US Patent 10,743,846, 2020 | | 2020 |
| Evaluation of saliva biomarkers in chronic obstructive pulmonary disease: correlation to patient reported outcomes N Patel | | 2016 |
| Reassessment Of Fixed Continuous Positive Airway Pressure In Obstructive Sleep Apnoea N Patel, HM Stone, M Allen, R Haqqee A74. LABORATORY AND MANAGEMENT ISSUES FOR SLEEP DISORDERS, A6369-A6369, 2011 | | 2011 |
| Kaur, Dalbir; Mehta, Rajnikant L; Jarrett, Hugh; Jowett, Sue; Gale, Nicola; Turner, Alice M Spiteri, N Patel | | |
